Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Feb 10;6(1):366-75.
doi: 10.3390/cancers6010366.

The role of matrix metalloproteinases in colorectal cancer

Affiliations

The role of matrix metalloproteinases in colorectal cancer

Anan H Said et al. Cancers (Basel). .

Abstract

In the United States, colorectal cancer (CRC) is the third leading cause of cancer mortality, with limited treatment options for those with advanced disease. Matrix metalloproteinases (MMPs) are important for maintaining extracellular homeostasis but also play a prominent role in cancer cell invasion and dissemination. Expression levels of MMP-1, -2, -7, -9 and -13 correlate with worse outcomes; MMP-12 expression appears to be protective. Hence, MMPs are attractive therapeutic _targets. Previous clinical trials using broad-spectrum MMP inhibitors were disappointing because of off-_target toxicity and lack of efficacy. Now, the availability of safer, more selective inhibitors has renewed interest in therapeutic _targeting of MMPs.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Surveillance, Epidemiology, and End Results (SEER) Program. Stat Fact Sheets: Colon and Rectum Cancer. [(accessed on 25 October 2013)]. Available online: http://seer.Cancer.Gov/statfacts/html/colorect.Html/
    1. Howlader N., Noone A., Krapcho M., Neyman N., Aminou R., Waldron W., Altekruse S., Kosary C., Ruhl J., Tatalovich Z., et al. SEER Cancer Statistics Review, 1975–2008. National Cancer Institute; Bethesda, MD, USA: 2011.
    1. Hua H., Li M., Luo T., Yin Y., Jiang Y. Matrix metalloproteinases in tumorigenesis: An evolving paradigm. Cell. Mol. Life Sci. 2011;68:3853–3868. doi: 10.1007/s00018-011-0763-x. - DOI - PMC - PubMed
    1. Van der Jagt M.F., Wobbes T., Strobbe L.J., Sweep F.C., Span P.N. Metalloproteinases and their regulators in colorectal cancer. J. Surg. Oncol. 2010;101:259–269. - PubMed
    1. Hu J., van den Steen P.E., Sang Q.X., Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug Discov. 2007;6:480–498. doi: 10.1038/nrd2308. - DOI - PubMed

LinkOut - more resources

  NODES
twitter 2